• 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
GB United Kingdom
Stand No: 41C40
About Almac Group ‘Partnering to Advance Human Health' The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture. The international company is a privately owned organisation that has organically grown for 50 years and now employs in excess of 5,000 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).
GB United Kingdom
Stand No: 40F33
Helping our clients achieve Total Quality Assurance through custom, flexible, contract services from a single source, our scientists, auditors and regulatory experts work with you at every stage of development, providing GMP and CMC Laboratory Services, GMP Auditing, GLP/GCP Bioanalysis, Regulatory and Toxicology Consulting and Pharmaceutical Manufacturing Support. Our Good Laboratory Practice (GLP) and Good Manufacturing Practice (cGMP) laboratory network have provided high quality technical services for some of the world's largest and most innovative pharmaceutical companies. GMP and CMC Laboratory Services We provide regulatory-driven, phase-appropriate laboratory services in support of CMC programs seeing you through preformulation, formulation and product release. Our capabilities include centres of excellence for method development and validation, analysis, stability studies, extractables and leachables, solid state characterisation, cGMP quality control testing and cGMP batch release testing. Our teams have specialist expertise for complex medicines and drug delivery systems such as inhalation drug product development for pulmonary...
The Spark-Lab company, a research and development laboratory built exclusively on Polish capital, was created in 2010 and has been rapidly expanding ever since. Our team of executives consists of scientists affiliated with leading academic institutions in the Tricity area (Gdansk University of Technology, Medical University of Gdansk). The ever increasing demands towards production companies belonging to various branches of industry force a great amount of qualitative and quantitative standards for their products. Production process itself generates numerous problems on its various stages. Establishing internal research and developmnet departments requires vast financial resources to be invested in the purchase of measurement equipment as well as employment of highly qualified personnel. In an attempt to meet the growing needs of pharmaceutical, chemical and cosmetic sectors, Spark-Lab offers research and development services along with various routine analyses, thus serving as an external laboratory for your company. High-end measuring devices allow us to...
Sub-event: CPHI
Pharmaffiliates Analytics & Synthetics (P) Ltd, is an integrated CRO (Contract Reserach Organisition) established in year 2005. Presently we are US-FDA accredited Facility We are specialized in research via synthesis of complex and difficult to make compounds, innovative organic molecules to support and accelerate the drug discovery research of pharma and biotech companies. We adapt unique synthetic approaches and execute in robust ways for making complex and unknown impurities with their characterization data. Thus we make the drug discovery process more efficient, cost-effective while maintaining the highest standards of quality. With the collective efforts of our team of 130 scientists so, far, we have performed more than 300 method validations & many of these validation reports submitted to EU & US & sought approvals. Work is carried in line with the ICH and the GMP guidance. Our experience, combined with state-of- the-art laboratories and manufacturing facilities lets us become an...
Sub-event: CPHI
IT Italy
Stand No: 40B40
Since 2005 PolyCrystalline provides reliable solutions to optimise and control the crystallisation process of Active Pharmaceutical Ingredients for pharmaceutical companies. Our mission is to support our clients during drug development, helping them to reduce batch failure, avoiding costly crystallisation issues and overall offering greater confidence in drug quality during manufacturing. We can support you from early-phase drug discovery to kilogram supply. We are a high performing cohesive team of trained chemists and analysts, with more than 10 years of experience in the development and optimization of APIs crystallization. We care about results and innovation based on sound science and the use of modern technologies.